Compare Novartis AG (NVS) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Ferrari NV — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Ferrari NV trades at $367.23 (market cap $65.48B). The key difference: Novartis AG is far larger — about 4.4× Ferrari NV's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | RACE | |
|---|---|---|
Market Cap | $290.25B | $65.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $517.65 |
52-Week Low | $113.50 | $314.63 |
Enterprise Value | $330.27B | $66.69B |
Dividend Yield | 3.17% | 1.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
